Friday, November 21, 2008 - 5:21PM EST

Review Articles

1. Altered immunity as a risk factor for non-Hodgkin lymphoma.

Author
Grulich AE; Vajdic CM; Cozen W;
Institution
National Centre in HIV Epidemiology and Clinical Research, Level 2, 376 Victoria Street, Darlinghurst, NSW 2010, Australia. agrulich@nchecr.unsw.edu.au
Journal
Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):405-8. Epub 2007 Mar 2.
Abstract URL
Click here to view abstract

2. Primary CNS lymphoma.

Author
Batchelor T; Loeffler JS;
Institution
Stephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital, Boston, MA 02114, USA. tbatchelor@partners.org
Journal
J Clin Oncol. 2006 Mar 10;24(8):1281-8.
Abstract URL
Click here to view abstract

3. Coeliac disease and lymphoma.

Author
Kumar P;
Institution
Adult & Paediatric Gastroenterology, Barts & London Medical School, London, UK. p.j.kumar@qmul.ac.uk
Journal
Eur J Gastroenterol Hepatol. 2006 Feb;18(2):131-2.

4. Novel treatment strategies for aggressive non-Hodgkin's lymphoma.

Author
Fayad L; Younes A;
Institution
Department of Lymphoma/Myeloma, University of Texas, MD Anderson Cancer Center, Box # 429, Houston, TX 77030, USA.
Journal
Expert Opin Pharmacother. 2006 Apr;7(6):733-48.
Abstract URL
Click here to view abstract

5. Cure of incurable lymphoma.

Author
DeNardo GL; Sysko VV; DeNardo SJ;
Institution
Radiodiagnosis and Therapy, Division of Hematology/Oncology, University of California Davis Medical Center, Sacramento, CA, USA. gldenardo@ucdavis.edu
Journal
Int J Radiat Oncol Biol Phys. 2006;66(2 Suppl):S46-56.
Abstract URL
Click here to view abstract

6. Logistics of therapy with the ibritumomab tiuxetan regimen.

Author
Meredith RF;
Institution
Department of Radiation Oncology, University of Alabama Medical Center, Birmingham, AL, USA. rmeredith@uabmc.edu
Journal
Int J Radiat Oncol Biol Phys. 2006;66(2 Suppl):S35-8.
Abstract URL
Click here to view abstract

7. Ongoing investigations and new uses of radioimmunotherapy in the treatment of non-Hodgkin's lymphoma.

Author
Meredith RF;
Institution
Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA. rmeredith@uabmc.edu
Journal
Int J Radiat Oncol Biol Phys. 2006;66(2 Suppl):S23-9.
Abstract URL
Click here to view abstract

8. Antibody and immunomodulatory agents in treatment of indolent non-Hodgkin's lymphoma.

Author
Friedberg JW; Freedman AS;
Institution
James P. Wilmot Cancer Center, University of Rochester, 601 Elmwood Avenue, Box 704, Room 1-4118C, NY 14642, USA. jonathan_friedberg@urmc.rochester.edu
Journal
Curr Treat Options Oncol. 2006 Jul;7(4):276-84.
Abstract URL
Click here to view abstract

9. Primary intraocular lymphoma: A review.

Author
Choi JY; Kafkala C; Foster CS;
Institution
Retina Specialists of Boston, Cambridge, MA, USA.
Journal
Semin Ophthalmol. 2006 Jul-Sep;21(3):125-33.
Abstract URL
Click here to view abstract

10. The role of PET in lymphoma.

Author
Jhanwar YS; Straus DJ;
Institution
Nuclear Medicine Service, Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Journal
J Nucl Med. 2006 Aug;47(8):1326-34.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6